Changes in the evolution of a malignant transplantable tumor in mice to whom quinacrine, copper and zinc were supplied in drinking water are reported. Male AJ mice were inoculated in the right thigh with 1,000,000 TA3 or TA3 MTXR tumoral cells. Three experiments were designed with different types of tumors and different schedules of quinacrine and cations administered in drinking water. The animals that received quinacrine or quinacrine plus copper in drinking water had significantly smaller tumors, and some groups had a high rate of complete tumor regression (up to 60%). Quinacrine and copper have synergistic antineoplastic activity. Zinc salts do not improve the antitumoral effect of quinacrine. The relevant fact of this experiment lies in the fact that a large number of women using IUDs with copper could occasionally be treated with quinacrine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0010-7824(94)90070-1 | DOI Listing |
Eur J Contracept Reprod Health Care
April 2018
d School of Medicine , State University of New York at Buffalo, Buffalo , NY , USA.
Objectives: Determine the long-term risk of hysterectomy and ectopic pregnancy in women using the quinacrine hydrochloride pellet system of permanent contraception (QS) relative to the comparable risk in women using Copper T intrauterine device (IUD) or tubal ligation surgery (TL) for long-term or permanent contraception.
Methods: This was a retrospective cohort study, conducted in the Northern Vietnamese provinces of Ha Nam, Nam Dinh, Ninh Binh and Thai Binh. Women who had their first QS procedure, last IUD insertion or TL between 1989 and 1996 were interviewed regarding post-procedure health outcomes approximately 16 years post exposure.
Eur J Contracept Reprod Health Care
April 2017
d Department of Obstetrics and Gynecology , State University of New York at Buffalo, Buffalo , NY , USA.
Objectives: To determine the long-term risk of reproductive tract cancer in women using the quinacrine hydrochloride pellet system of permanent contraception (QS) relative to the comparable risk in women using Copper T intrauterine device (IUD) or tubal ligation surgery (TL) for long-term or permanent contraception.
Methods: This was a retrospective cohort study, conducted in the Northern Vietnamese provinces of Ha Nam, Nam Dinh, Ninh Binh and Thai Binh. Women who had their first QS procedure, last IUD insertion or TL between 1989 and 1996 were interviewed regarding post-procedure health outcomes, particularly reproductive tract cancers.
Contraception
August 2015
State University of New York at Buffalo, School of Medicine, 31 Hampton Hill Drive, Buffalo, NY 14221. Electronic address:
Dr. Jaime Zipper, the Chilean inventor of the quinacrine method of nonsurgical permanent contraception, was aware that when chest surgeons injected quinacrine into the pleural cavity to treat and prevent reoccurrence of pleural effusion, it resulted in the formation of fibrous adhesions between the lung and costal pleura. Zipper thought that a similar scarring effect could occur in the fallopian tubes if quinacrine was instilled into the uterine cavity.
View Article and Find Full Text PDFBiosens Bioelectron
March 2012
School of Chemical Engineering, University of Science and Technology Liaoning, 185 Qianshan Road, Anshan, Liaoning, 114051, China.
A novel strategy of amperometric assay for drug-dsDNA interactions was developed based on an inhibitory effect of antimararial drug (quinacrine) on an electrocatalytic activity of DNA-Cu(II) complex. In this method, a DNA-Cu(II) complex immobilized DNA/polyallylamine(PAA) polyion complex membrane was used as a sensing element. The electrocatalytic activity of a DNA-Cu(II) complex for hydrogen peroxide reduction was reversibly inhibited by electron blocking effect of quinacrine-dsDNA interaction and this inhibitory effect was amplified by the hydrogen peroxide reduction.
View Article and Find Full Text PDFFertil Steril
July 2009
School of Medicine, Department of Obstetrics and Gynecology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Objective: To evaluate the safety of nonsurgical quinacrine sterilization for HIV-positive (HIV+) women.
Design: An open trial of quinacrine sterilization was carried out in women infected with HIV and women who were HIV negative (HIV-). Comparison of the results with the two groups provided an assessment of the safety and effectiveness of quinacrine sterilization for HIV+ women.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!